Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial

Authors
Category Primary study
JournalLANCET GASTROENTEROLOGY & HEPATOLOGY
Year 2021
This article has no abstract
Epistemonikos ID: 815ce0e226261ee3fcf8ed08a22b4bc4b615bd44
First added on: Nov 22, 2025